492OOsimertinib for patients (pts) with leptomeningeal metastases (LM) associated with EGFRm advanced NSCLC. (25th November 2018) - Ahn, M-J; Chiu, C-H; Cheng, Y; Han, J-Y; Goldberg, S B; Greystoke, A; Crawford, J; Zhao, Y; Huang, X; Johnson, M; Vishwanathan, K; Mendoza-Naranjo, A; et al.